Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Clinical Investigation

• Publication date

  1994-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI117555PMID 7962548PMCID PMC294633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The determination of nucleic acids.

  2006cited by this paper
• Blockade of VIP during Neonatal Development Induces Neuronal Damage and Increases VIP and VIP Receptors in Brain

  1994cited by this paper
• Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: Relation to ontogenic events

  1994cited by this paper
• Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors.

  1994cited by this paper
• Differential signal transduction by five splice variants of the PACAP receptor

  1993cited by this paper
• Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.

  1993cited by this paper
• Cell cycle parameters and patterns of nuclear movement in the neocortical proliferative zone of the fetal mouse

  1993cited by this paper
• A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

  1993cited by this paper
• Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.

  1993cited by this paper
• The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

  1993cited by this paper
• Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

  1993cited by this paper
• Receptors for pituitary adenylate cyclase-activating polypeptide: comparison with vasoactive intestinal peptide receptors.

  1992cited by this paper
• Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain.

  1992cited by this paper
• Development of neurons and synapses in ochratoxin A-induced microcephalic mice: a quantitative assessment of somatosensory cortex.

  1992cited by this paper
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

  1992cited by this paper
• The germinative zone produces the most cortical astrocytes after neuronal migration in the developing mammalian brain.

  1992cited by this paper
• BUdR as an S-phase marker for quantitative studies of cytokinetic behaviour in the murine cerebral ventricular zone

  1992cited by this paper
• Early Neurogenesis and Teratogenesis in Whole Mouse Embryo Cultures. Histochemical, Immunocytological and Ultrastructural Study of the Premigratory Neuronal‐glial Units in Normal Mouse Embryo and in Mouse Embryos Influenced by Cocaine and Retinoic Acid

  1992cited by this paper
• An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

  1991cited by this paper
• The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1–27) and PACAP (1–38)) interact with distinct receptors on rat pancreatic AR 4‐2J cell membranes

  1991influential reference
• Early neurobehavioral disorders in the micrencephalic offspring induced by prenatal treatment with N-methyl-N-nitrosourea or methylazoxymethanol in the rat.

  1991cited by this paper
• A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.

  1991cited by this paper
• Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.

  1991influential reference
• Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

  1990cited by this paper
• Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts

  1990cited by this paper
• Behavioral deficits in rats with minimal cortical hypoplasia induced by methylazoxymethanol acetate.

  1990cited by this paper
• Microcephaly: general considerations and aids to nosology.

  1990cited by this paper
• Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen

  1990cited by this paper
• A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting

  1990cited by this paper
• Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist.

  1989cited by this paper
• Dynamic structure of the radial glial fiber system of the developing murine cerebral wall. An immunocytochemical analysis.

  1989cited by this paper
• The contribution of primary and secondary neuronal degeneration to prenatally-induced micrencephaly.

  1988cited by this paper
• Identification of radial glial cells within the developing murine central nervous system: studies based upon a new immunohistochemical marker.

  1988cited by this paper
• Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide

  1987cited by this paper
• Vasoactive intestinal peptide and electrical activity influence neuronal survival.

  1986cited by this paper
• Glial-neuronal relationship in the developing central nervous system. A histochemical-electron microscope study of radial glial cell particulate glycogen in normal and reeler mice and the human fetus.

  1985cited by this paper
• Methylazoxymethanol microencephaly in rats: neurochemical characterization and behavioral studies with the nootropic oxiracetam.

  1984cited by this paper
• Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

  1982cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper

• Constitutive and conditional deletion reveals distinct phenotypes driven by developmental versus neurotransmitter actions of the neuropeptide PACAP

  2023cites this paper
• PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism

  2023cites this paper
• VPAC1 and VPAC2 receptor deficiencies negatively influence pregnancy outcome through distinct and overlapping modulations of immune, trophoblast and vascular functions.

  2022cites this paper
• From decidualization to pregnancy progression: An overview of immune and metabolic effects of VIP

  2022cites this paper
• Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): Autism, schizophrenia, and Alzheimer’s disease

  2020cites this paper
• Shengui Sansheng Pulvis maintains blood-brain barrier integrity by vasoactive intestinal peptide after ischemic stroke.

  2019cites this paper
• Developmental Disorders

  2019cites this paper
• Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts

  2019cites this paper
• Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice

  2018cites this paper
• Active immunization against vasoactive intestinal polypeptide decreases neuronal recruitment and inhibits reproduction in zebra finches

  2016cites this paper
• Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways

  2016cites this paper
• Vascular regulation of embryonic neurogenesis

  2016cites this paper
• Regulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP)

  2015cites this paper
• ADNP: A major autism mutated gene is differentially distributed (age and gender) in the songbird brain.

  2015cites this paper
• Parasympathetic innervation regulates tubulogenesis in the developing salivary gland.

  2014cites this paper
• Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors

  2014influential citation
• PACAP and PAC1 receptor in brain development and behavior.

  2013cites this paper
• Chapter 128 – VIP

  2013cites this paper
• Voie Hedgehog et système VIP-récepteurs dans des cellules de glioblastome

  2013cites this paper
• Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP)

  2012cites this paper
• Multipotent Stem Cells in the Embryonic Nervous System

  2012cites this paper
• VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

  2011cites this paper
• VIP-induced neuroprotection of the developing brain.

  2011cites this paper
• VIP and PACAP.

  2010cites this paper
• Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice.

  2009cites this paper
• VIP, From Gene to Behavior and Back: Summarizing my 25 Years of Research

  2008cites this paper
• Mice Deficient in both Pituitary Adenylyl Cyclase-activating Polypeptide and Vasoactive Intestinal Peptide Survive, but Display Growth Retardation and Sex-dependent Early Death

  2008cites this paper
• Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice.

  2008cites this paper
• Regardless of genotype, offspring of VIP‐deficient female mice exhibit developmental delays and deficits in social behavior

  2008influential citation
• Inhibition of human neuroblastoma growth by a specific VIP antagonist

  2007cites this paper
• The Effect of Binge Fetal Alcohol Exposure on the Number of Vasoactive Intestinal Peptide-Producing Neurons in Fetal Sheep Brain

  2007cites this paper
• Neonatal mice of the down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation

  2007cites this paper
• Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.

  2007cites this paper
• Activity-dependent neurotrophic factor (ADNF)

  2007cites this paper
• From Concept to Potential Therapeutics: Neuroprotective Peptides

  2007cites this paper
• Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

  2007cites this paper
• Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry

  2007influential citation
• Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring.

  2007cites this paper
• Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.

  2006cites this paper
• Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.

  2005cites this paper
• VPAC2 Receptors Mediate Vasoactive Intestinal Peptide-Induced Neuroprotection against Neonatal Excitotoxic Brain Lesions in Mice

  2005cites this paper
• Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult.

  2005cites this paper
• Effects of in ovo treatment with PACAP antagonist on general activity, motor and social behavior of chickens.

  2004cites this paper
• Clinical endocrinology and metabolism. Potential clinical applications of vasoactive intestinal peptide: a selected update.

  2004cites this paper
• Neurotransmitters co-existing with VIP or PACAP.

  2004cites this paper
• The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

  2003cites this paper
• Expression and regulation of two RFamide peptide genes in the rat

  2003cites this paper
• The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.

  2003cites this paper
• VIP as a trophic factor in the CNS and cancer cells.

  2003cites this paper
• Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome.

  2003cites this paper
• Developmental Diseases of the Nervous System

  2003cites this paper
• Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

  2003cites this paper
• Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse.

  2002cites this paper
• Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development.

  2002cites this paper
• Methodologic issues in epidemiologic studies of congenital microcephaly.

  2002cites this paper
• The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase.

  2002cites this paper
• Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.

  2002cites this paper
• Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate.

  2002cites this paper
• DPIV — Natural Substrates of Medical Importance

  2002cites this paper
• Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model.

  2002cites this paper
• Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.

  2001cites this paper
• Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation

  2001cites this paper
• IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growth.

  2001cites this paper
• Organization of vasoactive intestinal peptide-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development.

  2001cites this paper
• THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY

  2000cites this paper
• [Cortical dysgenesis. Current views on pathogenesis and pathophysiology].

  2000cites this paper
• A Glia-Derived Signal Regulating Neuronal Differentiation

  2000cites this paper
• Caffeine induces in vivo premature appearance of telencephalic vesicles.

  2000cites this paper
• VIP and PACAP 38 Modulate Ibotenate‐Induced Neuronal Heterotopias in the Newborn Hamster Neocortex

  2000cites this paper
• The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.

  2000cites this paper
• Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

  2000cites this paper
• The Viktor Mutt Memorial Lecture Protection by VIP and Related Peptides Against Cell Death and Tissue Injury

  2000cites this paper
• Growth–Inhibitory Effect of Prostasomes on Prostatic Cancer Cell Lines in Culture

  2000cites this paper
• Brain PACAP/VIP receptors: regional distribution, functional properties and physiological relevance.

  2000cites this paper
• Prenatal Blockade of Vasoactive Intestinal Peptide Alters Cell Death and Synaptic Equipment in the Murine Neocortex

  2000cites this paper
• Distribution of vasoactive intestinal peptide-like immunoreactivity in the brain and pituitary of the frog (Rana esculenta) during development.

  1999cites this paper
• VIP and PACAP: very important in pain?

  1999cites this paper
• [Interstrain differences in the the behavior of mice selected for greater and lesser brain mass].

  1999cites this paper
• VIP Neuroprotection against Excitotoxic Lesions of the Developing Mouse Brain

  1999cites this paper
• Pharmaceutical VIP: prospects and problems.

  1999cites this paper
• Vasoactive Intestinal Peptide Regulates Embryonic Growth Through the Action of Activity‐dependent Neurotrophic Factor

  1999cites this paper
• Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives.

  1999cites this paper
• Regulation of Postimplantation Mouse Embryonic Growth by Maternal Vasoactive Intestinal Peptide

  1999cites this paper
• Activity-dependent neurotrophic factor: a potent regulator of embryonic growth and development

  1999cites this paper
• [Prenatal inhibition of intestinal vasoactive peptide and cerebral excitatory lesions in the newborn mouse].

  1999cites this paper
• Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth.

  1999cites this paper
• Inhibition prénatale du peptide vasoactif intestinal et lésions cérébrales excitotoxiques du souriceau nouveau-né

  1999cites this paper
• Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis.

  1998cites this paper
• Expression of PACAP, and PACAP type 1 (PAC1) receptor mRNA during development of the mouse embryo.

  1998cites this paper
• Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

  1998cites this paper
• Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos

  1998cites this paper
• Regulation of neurogenesis by growth factors and neurotransmitters.

  1998cites this paper
• Involvement of Pituitary Adenylate Cyclase‐Activating Polypeptide II Vasoactive Intestinal Peptide 2 Receptor in Mouse Neocortical Astrocytogenesis

  1998cites this paper
• Vasoactive intestinal peptide is an important endocrine regulatory factor of fetal rat testicular steroidogenesis.

  1998cites this paper
• International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

  1998cites this paper
• Protection Against Developmental Deficiencies by a Lipophilic VIP Analogue

  1998cites this paper
• Le peptide vasoactif intestinal : un nouveau facteur neurotrophique

  1998cites this paper
• Multiple Actions of a Hybrid PACAP Antagonist: Neuronal Cell Killing and Inhibition of Sperm Motility a

  1998cites this paper
• Perinatal aspects of preterm intrauterine growth restriction

  1998cites this paper
• Microlissencephaly: A Heterogeneous Malformation of Cortical Development

  1998cites this paper